Skip to main content

Table 2 Prevalence of Anti-C.trachomatis antibodies (IgG and IgM) in the serum of unexplained infertility cases in relation to the type and duration of infertility

From: Screening for Chlamydia trachomatis in Egyptian women with unexplained infertility, comparing real-time PCR techniques to standard serology tests: case control study

Anti-C.trachomatis antibodies

Type of infertility

Total (n = 50)

Duration of infertility

1ry (n = 36)

2ry (n = 14)

<5 years (n = 26)

>5 years (n = 24)

Data presented with frequency (%)

IgM + ve

1.0 (2.8 %)

2.0 (14.3 %)

3.0 (6 %)

2.0 (7.7 %)

1.0 (2.9 %)

IgM-ve

35 (97.2 %)

12 (85.7 %)

47 (94 %)

24 (92.3 %)

34 (97.1 %)

IgG + ve

14 (38.9 %)

4.0 (28.6 %)

18 (36 %)

9.0 (34.6 %)

9.0 (25.7 %)

IgG –ve

19 (52.7 %)

10 (71.4 %)

29 (58 %)

15 (57.6 %)

24 (68.6 %)

Equivocal IgG

2.0 (5.6 %)

1.0 (7.1 %)

3.0 (6 %)

2.0 (7.7 %)

2.0 (5.7 %)

The mean ratios for anti-C.trachomatis IgG and IgM using the ELISA technique.

Data presented with mean ± S.D

P

 

p

Ratio of IgG*

1.29 ± 1.0

1.19 ± 1.0

0.63

1.22 ± 0.9

1.31 ± 1.0

0.52

Ratio of IgM*

0.37 ± 0.2

0.42 ± 0.3

0.52

0.38 ± 0.2

0.37 ± 0.2

0.42

  1. *Values are expressed in terms of mean ± S.D.; p-value, ratios >1.1 considered positive and <0.9 considered negative